Halozyme Therapeutics, Inc. HALO
$111.93
+2.05%
at last close
Dividend
Halozyme Therapeutics, Inc. (HALO) does not currently pay a regular dividend, based on the most recent data available. Companies that retain earnings instead of paying dividends often reinvest in growth; check the financials page for how Halozyme Therapeutics, Inc. deploys its earnings.
Key Stats
- Last Close
- $111.93
- Market Cap
- $12.45 billion
- 52-Week Range
- $61.23 – $112.05
- Average Volume
- 2.21 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.